New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

BioStem Technologies, Inc. (BSEM) vs Pluri Inc. (PLUR)

BioStem Technologies, Inc. and Pluri Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Pluri Inc. are of similar size ($13.9M and $13.6M). Pluri Inc. grew revenue faster over the last twelve months: 10.0% against −83.9%. BioStem Technologies, Inc. has the higher net margin (−121.0% vs −1,943.9%) and the higher return on invested capital (−7.07% vs −436.8%). Across the 11 metrics below, BioStem Technologies, Inc. leads on 7 and Pluri Inc. on 4.

Valuation

Metric BSEM PLUR Biotechnology median
P/E n/m n/m 8.49
P/S 0.36 7.85 8.56
P/B 0.62 n/m 2.04
Price to free cash flow — n/m 23.84
EV/EBITDA n/m n/m 0.69
EV/Sales 0.33 22.66 8.00
Earnings yield (348.67%) (325.96%) (35.81%)
Free cash flow yield — (167.81%) (25.41%)

Profitability

Metric BSEM PLUR Biotechnology median
Gross margin 79.83% 51.95% 70.18%
Operating margin (6.18%) (2,341.12%) 0.00%
Net margin (121.02%) (1,943.87%) 0.00%
Free cash flow margin — (1,316.52%) 0.00%
Return on equity — 253.49% (51.58%)
Return on assets — (96.79%) (45.91%)
Return on invested capital (7.07%) (436.83%) 0.00%

Growth

Metric BSEM PLUR Biotechnology median
Revenue growth (TTM) (83.87%) 10.03% 7.20%
EPS growth (last fiscal year) (126.53%) 31.46% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric BSEM PLUR Biotechnology median
Debt to equity 0.00 (1.75) 0.00
Current ratio 0.73 0.27 4.79
Net debt to EBITDA — (0.83) 1.01

Dividend

Metric BSEM PLUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM PLUR Biotechnology median
Market cap 13.57m 13.94m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack